Do Links Count? FDA To Re-Examine Online Drug Ads
11/10/2016 7:46:38 AM
It’s back to the drawing board for the FDA.
After years of slow reaction to pharma marketing online, the agency announced this week a new research initiative to better understand how consumers process short-form posts and ads.
More precisely, the FDA is trying to determine whether links in tweets and Google ads can independently convey all the necessary information about product risk.
comments powered by